The Egyptian Journal of Radiology and Nuclear Medicine · 2012 · 15 citations · 23 references
MedicineNeurologyRadiologyDiagnostic RadiologyMagnetic Resonance BiophysicsNeuroradiologyMagnetic Resonance ImagingMagnetic Resonance SpectroscopySpinal Cord ImagingCervical Myelopathy AssessmentCervical Spondylotic MyelopathyMagnetic ResonanceMetabolic MyelopathyMetabolic Rate ChangesNuclear Magnetic Resonance SpectroscopySpinal Cord Signal Changes
To assess the diagnostic value of magnetic resonance spectroscopy (MRS) in the evaluation of cervical spinal cord biochemical changes in patients with cervical spondylotic myelopathy (CSM). Twenty-four patients with cervical spondylotic myelopathy (patient group) and eleven age matched neurologically free volunteers (control group) underwent magnetic resonance imaging. MRS was assessed for the main metabolites including N-acetylaspartate (NAA), Choline (Cho), Creatine (Cr) and Lactate (Lac). The MRS findings of both groups were compared. Significant reduction in NAA/Cr ratio of patients with CSM (mean = 1.34 ± 0.09) in comparison to controls (mean = 1.82 ± 0.08). No significant differences in Cho/Cr ratio between both groups. Lactate peak was detected in nine patients while it was not detected in any of the controls. The difference in NAA/Cr ratio between patients with Lac peak and those without Lac peak was insignificant. MRS is a promising non invasive technique that can help to evaluate metabolic changes of the cervical cord in cervical spondylotic myelopathy even in normally looking-areas.
23
MR T2 Image Classification in Cervical Compression Myelopathy
Yasutsugu Yukawa, Fumihiko Kato, Hisatake Yoshihara et al. · Spine · 2007 · 208 citations